| Christian Abreu-ramirez, MD | |
|
1324 Lakeland Hills Blvd, Lakeland, FL 33805-4543 | |
| (863) 687-1100 | |
| Not Available |
| Full Name | Christian Abreu-ramirez |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 13 Years |
| Location | 1324 Lakeland Hills Blvd, Lakeland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003335019 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeland Regional Medical Center | Lakeland, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeland Regional Health Systems Inc | 8325952914 | 346 |
News Archive
The COVID-19 crisis is not impacting cardiovascular procedures as heavily as it is other therapy areas, since the majority of these procedures are essential, according to GlobalData, a leading data and analytics company. GlobalData estimates that 96.7% of cardiovascular procedures performed in the US are essential procedures.
Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound renal denervation (RDN) to a sham procedure for treatment-resistant hypertension (HTN) found that the addition of a pharmacologic intervention led to further blood pressure reductions after RDN with a smaller increase in additional medications prescribed and less use of diuretics.
Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.
Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 9 days ago
| Entity Name | Lakeland Regional Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497748743 PECOS PAC ID: 8325952914 Enrollment ID: O20031118000384 |
News Archive
The COVID-19 crisis is not impacting cardiovascular procedures as heavily as it is other therapy areas, since the majority of these procedures are essential, according to GlobalData, a leading data and analytics company. GlobalData estimates that 96.7% of cardiovascular procedures performed in the US are essential procedures.
Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound renal denervation (RDN) to a sham procedure for treatment-resistant hypertension (HTN) found that the addition of a pharmacologic intervention led to further blood pressure reductions after RDN with a smaller increase in additional medications prescribed and less use of diuretics.
Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.
Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christian Abreu-ramirez, MD 9603 Cafe Ter, San Antonio, TX 78251-4989 Ph: (347) 461-1114 | Christian Abreu-ramirez, MD 1324 Lakeland Hills Blvd, Lakeland, FL 33805-4543 Ph: (863) 687-1100 |
News Archive
The COVID-19 crisis is not impacting cardiovascular procedures as heavily as it is other therapy areas, since the majority of these procedures are essential, according to GlobalData, a leading data and analytics company. GlobalData estimates that 96.7% of cardiovascular procedures performed in the US are essential procedures.
Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound renal denervation (RDN) to a sham procedure for treatment-resistant hypertension (HTN) found that the addition of a pharmacologic intervention led to further blood pressure reductions after RDN with a smaller increase in additional medications prescribed and less use of diuretics.
Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.
Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis.
› Verified 9 days ago
Dr. Elijah Kim, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1321 Fax: 863-284-1786 | |
Dr. Julia Mcneice, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 | |
Robert H Bevis, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 | |
Dr. Lilliam S. Chiques-colon, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Dr. Lijian Wang, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Eric Lipson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 |